Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Cells ; 9(2)2020 02 20.
Article in English | MEDLINE | ID: mdl-32093269

ABSTRACT

Investigation of interactions between a pro-inflammatory cytokine tumor necrosis factor (TNFα) and its receptor is required for the development of new treatments for autoimmune diseases associated with the adverse effects of TNFα. Earlier, we demonstrated that the innate immunity protein Tag7 (PGRP-S, PGLYRP1) can interact with the TNFα receptor, TNFR1, and block the transduction of apoptotic signals through this receptor. A complex formed between the Tag7 protein and the major heat shock protein Hsp70 can activate TNFR1 receptor and induce tumor cell death via either apoptotic or necroptotic pathway. In this study, we show that a 12-mer peptide, designated 17.1, which was derived from the Tag7 protein, can be regarded as a novel TNFα inhibitor, also is able to form a cytotoxic complex with the heat shock protein Hsp70. This finding demonstrates a new role for Hsp70 protein in the immune response. Also, this new inhibitory 17.1 peptide demonstrates an anti-inflammatory activity in the complete Freund's adjuvant (CFA)-induced autoimmune arthritis model in laboratory mice. It appears that the 17.1 peptide could potentially be used as an anti-inflammatory agent.


Subject(s)
Anti-Inflammatory Agents/metabolism , Anti-Inflammatory Agents/pharmacology , Apoptosis/drug effects , Cytokines/chemistry , HSP70 Heat-Shock Proteins/metabolism , Peptides/metabolism , Peptides/pharmacology , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Animals , Anti-Inflammatory Agents/therapeutic use , Arthritis, Rheumatoid/chemically induced , Arthritis, Rheumatoid/drug therapy , Cytokines/immunology , Disease Models, Animal , Female , Fibroblasts/metabolism , Freund's Adjuvant/adverse effects , HEK293 Cells , Humans , Immunity, Innate , Mice , Mice, Inbred ICR , Necroptosis/drug effects , Peptides/therapeutic use , Protein Binding , Receptors, Tumor Necrosis Factor, Type I/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/immunology , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...